tiprankstipranks

Jeffrey Meckler Insider Profile

4 Followers
Jeffrey Meckler, Director at Travere Therapeutics, holds 81.00K shares in Travere Therapeutics (Ticker: TVTX), holds 75.37K shares in Indaptus Therapeutics (Ticker: INDP), holds 107.00K shares in Novelion Therapeutics (Ticker: NVLNF).
tipranks
Jeffrey Meckler

Jeffrey Meckler
Travere Therapeutics (TVTX)
Director

Ranked #69,141 out of 98,042 Corporate Insiders

Profitable Transactions

46%
6 out of 13 Profitable Transactions

Average Return

-7.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$954K
83.18%
16.82%
0.00%
A breakdown of Jeffrey Meckler's holdings

Insider Roles

Travere Therapeutics
(TVTX)
Director
Indaptus Therapeutics
(INDP)
CEO and Director, Director
SurModics
(SRDX)
See Explanation of Responses
Roles that Jeffrey Meckler holds in companies

Most Profitable Insider Trade

Stock:
Travere Therapeutics
(TVTX)
Rating:Informative Buy
Date:Nov 25, 2014 - Nov 25, 2015
Return:+146.80%
The most profitable trade made by Jeffrey Meckler

Jeffrey Meckler's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Travere Therapeutics
May 10, 2024
Director
Uninformative Buy
$793.80K
Indaptus Therapeutics
Nov 22, 2022
CEO and Director, Director
Informative Buy
18.94K
$160.55K
NVLNF
Novelion Therapeutics
Jul 01, 2015
Informative Buy
87.13K
$75.11K
SurModics
See Explanation of Responses
$0.00
List of latest transactions for each holding click on a transaction to see Jeffrey Meckler's performance on stock

Jeffrey Meckler insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey Meckler?
The percentage of profitable transactions made by Jeffrey Meckler is 46%.
    What is the average return per transaction made by Jeffrey Meckler?
    The average return per transaction made by Jeffrey Meckler is -7.20%.
      What stocks does Jeffrey Meckler hold?
      Jeffrey Meckler holds: TVTX, INDP, NVLNF, SRDX stocks.
        What was Jeffrey Meckler’s latest transaction?
        Jeffrey Meckler latest transaction was an Uninformative Buy of ―.
          What was Jeffrey Meckler's most profitable transaction?
          Jeffrey Meckler’s most profitable transaction was an Informative Buy of TVTX stock on November 25, 2014. The return on the trade was 146.80%.
            What is Jeffrey Meckler's role in Travere Therapeutics?
            Jeffrey Meckler's role in Travere Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.